Results 51 to 60 of about 7,992 (245)
Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders
Endocrine Regulations, 2022 Proton pump inhibitors (PPIs) are the most widely prescribed medications in the world. According to numerous studies, PPIs have been linked to hyperprolactinemia, which can lead to a variety of sexual and reproductive issues.
Ashfaq Muhammad +2 more
doaj +1 more source
Cureus, 2018 Hyperprolactinemia is a common finding in primary hypothyroidism, but increased prolactin in the setting of subclinical hypothyroidism (SCH) has been scarcely reported in the literature.
Kashif Aziz +4 more
semanticscholar +1 more source
Nipple discharge: the state of the art [PDF]
, 2019 Over 80% of females experience nipple discharge during their life. Differently from lactational (milk production) and physiological (white, green, or yellow), which are usually bilateral and involving multiple ducts, pathologic nipple discharge (PND ...
Panzironi, Giovanna +2 more
core +1 more source
Galactorrhea and hyperprolactinemia during vortioxetine use: case report
Turkish Journal of Biochemistry, 2018 Background: Hyperprolactinemia is one of the most common endocrine disorders of the hypothalamic-pituitary axis. Hyperprolactinemia and galactorrhea are rarely seen as adverse effects of antidepressant drugs.
H. Ozkan
semanticscholar +1 more source
The birth and rise of a craniopharyngioma: the radiological evolution of an incidental craniopharyngioma detected on serial MRI during medical treatment of a macroprolactinoma [PDF]
, 2016 This case demonstrates the rare coexistence of a prolactinoma with craniopharyngioma and documents its radiological growth. This case suggests that patients with pituitary neoplasms should be followed closely and although prolactinomas can often be ...
Losa, Marco +3 more
core +1 more source
Incidence of Galactorrhea in Young Women Using Depot-Medroxyprogesterone Acetate
The Scientific World Journal, 2006 Galactorrhea is rarely mentioned as a possible side effect of the use of Depot-Medroxyprogesterone Acetate (DMPA). Over the last few years, we have noticed an increased number of patients complaining of galactorrhea. A review of clinical data showed that
Hatim A. Omar +4 more
doaj +1 more source
Clinical Psychopharmacology and Neuroscience, 2017 Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine.
Mehmet A. Camkurt +3 more
semanticscholar +1 more source
Journal of Neuroendocrinology, Volume 37, Issue 3, March 2025.The thera(g)nostic approach with somatostatin analog‐based agents extends beyond gastroenteropancreatic neuroendocrine tumors. Understanding tumor biological mechanisms is essential for optimizing treatment strategies. Abstract First isolated by Brazeau et al. in 1972, somatostatin (SST) is a neuropeptide known for regulating various signaling pathways
Giulia Santo +3 more
wiley +1 more source
Pharmacology Research &Perspectives, Volume 13, Issue 1, February 2025.ABSTRACT Drug repurposing provides a cost‐effective and time‐saving approach to cancer therapy. Aripiprazole (ARI), a third‐generation antipsychotic, has shown potential anticancer properties by modulating pathways central to tumor progression and resistance.
Liam A. O'Callaghan +4 more
wiley +1 more source
Prolactinomas: Aspectos neurocirúrgicos Prolactinomas: neurosurgical aspects
Arquivos de Neuro-Psiquiatria, 2002 Relatamos nossa experiência com 38 casos de prolactinomas. Os adenomas foram divididos em três grupos. Os adenomas mono-hormonais tendem a ser microadenomas e manifestam-se com as alterações típicas deste tipo de tumor.
Oswaldo Inácio Tella Jr +3 more
doaj +1 more source